Clarity in every comparison.What was approved?
Health Canada announced Sevmia as the first generic semaglutide authorized for weight loss in Canada on June 29, 2026. Its reference product is Wegovy.
A generic product should be checked against its specific reference, authorized uses, strength and presentation. A shared ingredient does not mean every semaglutide product can be substituted for every other one.
Product identity
4 mg / 3 mL · selected presentation. Selected DIN from the indexed Health Canada record; not a complete list of presentations.
This is a selected product record, not a full catalogue of presentations. Match the DIN on your prescription or package to the current Health Canada entry.
Price and pharmacy availability
Stock not verified. We have not verified a current cash quote for this exact product and package. Ask the pharmacy about stock, quantity, days supplied, dispensing charges and whether a recall affects the supplied lot.
Coverage and substitution
Ask the insurer about this DIN and the plan’s authorization requirements. Ask your pharmacist and prescriber whether any proposed substitution fits your prescription. Approval alone does not confirm provincial interchangeability, coverage or local stock.